Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03624907 · ClinicalTrials.gov registry record · NA
Daily vs. Non-Daily SBRT for NSCLC
A NA study, sponsored by University of Florida.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03624907 is a NA study that was terminated before completion, run by University of Florida. The registered enrollment target is 20 participants.
The verdict
NCT03624907, a NA study, was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if stereotactic body radiotherapy (SBRT) on non-consecutive days will increase the chances of curing non-small cell lung cancer when compared to daily treatment.
Interventions
- RADIATION Daily Stereotactic Body Radiotherapy
- RADIATION Non-Daily Stereotactic Body Radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-10-19 |
| Est. Completion | 2021-06-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03624907
The ClinicalTrials.gov registry entry for NCT03624907 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Daily Stereotactic Body Radiotherapy is the first listed.
NCT03624907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03624907 about?
NCT03624907 is a clinical study titled "Daily vs. Non-Daily SBRT for NSCLC". The purpose of this study is to determine if stereotactic body radiotherapy (SBRT) on non-consecutive days will increase the chances of curing non-small cell lung cancer when compared to daily treatment.
What is the current status of trial NCT03624907?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2018-10-19. Estimated completion is 2021-06-16.
What interventions are being tested in trial NCT03624907?
The interventions under investigation include: Daily Stereotactic Body Radiotherapy (RADIATION), Non-Daily Stereotactic Body Radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT03624907?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.